Amarantus BioScience Holdings, Inc. Stock
Equities
AMBS
US02300U2050
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | -80.00% |
Financials (USD)
Sales 2014 | - | Sales 2015 | - | Capitalization | 8.57M |
---|---|---|---|---|---|
Net income 2014 | -27M | Net income 2015 | -25M | EV / Sales 2014 | - |
Net cash position 2014 | 89K | Net Debt 2015 | 2.96M | EV / Sales 2015 | - |
P/E ratio 2014 |
-2.06
x | P/E ratio 2015 |
-0.15
x | Employees | 12 |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 08-01-13 | |
Founder | 41 | 08-01-13 | |
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Founder | 79 | 08-01-13 | |
Founder | 41 | 08-01-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.000001 | 0.00% | 1,219,564 |
24-04-22 | 0.000001 | -99.00% | 43,100 |
24-04-18 | 0.0001 | 0.00% | 200,000 |
Delayed Quote OTC Markets, April 23, 2024 at 01:20 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-80.00% | 630 | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- AMBS Stock